Your search returned 12 studies. (Get alerts for new studies):
- A Trial of RAD001 and Avastin in Children With Recurrent Solid Tumors
Conditions: Recurrent or Refractory Solid Tumors - CNS Malignancies
1 Location available
- A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
Conditions: B-cell Malignancies
6 Locations available
- A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Conditions: Lymphoblastic Leukemia, Acute, Childhood - Myelogenous Leukemia, Acute, Childhood - Hodgkin's Disease - Non-Hodgkin's Lymphoma
1 Location available
- Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Lymphoid Malignancies and Select Un
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Chronic Lymphocytic Leukemia - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Con
1 Location available
- A Phase II Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Conditions: Thymoma - Thymus Cancer - Thymic Carcinoma
1 Location available
- A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Conditions: Hematologic Malignancies - Acute Leukemia - Myelodysplastic Syndrome (MDS) - Specific Subtypes of Refractory Anemia (RA) or Refractory Anemia With Ringed Sideroblasts(RARS) Subtypes - Myeloproliferative Disorder (MPD) - Hodgkin's Lymphoma - Non-Hodgkin's
1 Location available
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Infantile Leukemia (Both AML and ALL) - Myelodysplastic Syndrome - Myelodysplastic/Myeloproliferative Neoplasms - Biphenotypic Leukemia
1 Location available
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphocytic, Acute, T-Cell - Juvenile Myelomonocytic Leukemia Lymphoblastic - T-cell Lymphoblastic Lymphoma - Myelodysplastic Syndrome
1 Location available
- Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
Conditions: Non-hodgkins Lymphoma - Hodgkins Lymphoma - Multiple Myeloma
1 Location available
- Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
Conditions: Relapsed Lymphoma - B Cell Non-Hodgkin Lymphoma - Refractory Lymphoma - High Risk Chronic Lymphocytic Leukemia
1 Location available
- Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
Conditions: Lymphoma
1 Location available
- Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Conditions: Leukemia
1 Location available
|